Molecular Characterization Of Blandm And Blaoxa-48 Gene In Carbapenam Resistant Klebsiella Species At A Tertiary Care Centre
DOI:
https://doi.org/10.52783/jns.v14.3453Keywords:
CRKP, CLSI, DNA, blaNDM, blaOXA-48, PCRAbstract
Introduction: Carbapenems are the last resort drugs used to treat multidrug resistant (MDR) bacterial infections. The incidence of carbapenem resistance is increasing across the globe. Treatment failure and eventually high mortality were reported among individuals with carbapenem resistant bacterial infections. The incidence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections is increasing globally. The blaNDM is the predominant carbapenem-resistant gene in CRKP isolates. However, blaOXA-48 has also been reported to be increasing in recent days.
Aim And Objective: To study the molecular characterization of blaNDM and blaOXA-48 gene in carbapenam resistant klebsiella isolates.
Material And Methods: This was a Cross sectional study carried out in the Department of Microbiology for a period of 18 months i.e, November 2022 to May 2023. A total of 300 Klebsiella species from the isolates were tested collected from hospitalized and consultation patients were included in the study. The Antimicrobial susceptibility testing was performed according to the CLSI guidelines . The DNA extraction was done using the Qiagen DNA extraction kit and the resistant gene blaNDM and blaOXA-48 was detected using the PCR.
Results: A total of 300 Klebsiella species from the isolates were tested out of which Carbapenamses resistant kKbspp was observed to be 204(68%) and Carbapenamses sensitive Kbspp with 96 (32%) with the prevalence rate of 68%. The ratio of females was observed to be more as compared to the males with 64% and 36% respectively with the age group of 30-40 (38.7%) been affected the most. The maximum isolates were from urine (55%) and least for body fluid with 3%. The Ratio of Male/Female amongst Carbapenamses resistant klebsiella isolates was observed to be 32.9% and 67.1 % respectively. The age group 30-40 was the most commonly affected in Carbapenamses resistant klebsiella isolates with the urine cases most commonly found with 51.4%. The molecular characterization confirms BLANDM gene 48 (23.5%) and BLAOXA-48 with 57 (27.9%) was expressed.
Conclusion: CRKP is emerging as a serious threat among drug-resistant bacterial pathogens which would complicate the treatment of bacterial infections with available antibiotics. Performing regular surveillance studies in hospitals is very important to identify the circulating genes among carbapenem-resistant bacteria which will help to overcome the therapeutic challenges in treating the patients infected with CRKP
Downloads
Metrics
References
T Karampatakis, K Tsergouli, P. Behzadi. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics (Basel). 2023; 12 p. 234
Xu Z, Li B, Jiang Y, Huang J, Su L, Wu W, Pang Q, Li Z, Zhang J, Li X, Wang J, Cen F, Peng L, Liang J, Wang F, Liu C, Shen C, Liu Y, Yang Y. Development of a quadruple qRT-PCR assay for simultaneous identification of hypervirulent and carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr. 2024; 12(1):e0071923.
Revisiting ESKAPE pathogens: virulence, resistance, and combating strategies focusing on quorum sensing. Venkateswaran P, Vasudevan S, David H, Shaktivel A, Shanmugam K, Neelakantan P, Solomon AP. Front Cell Infect Microbiol. 2023; 13:1159798.
Shrestha R, Luterbach CL, Dai W, et al. Characteristics of community-acquired carbapenem-resistant Enterobacterales. J Antimicrob Chemother. 2022; 77(10):2763–2771.
Hypervirulence and multiresistance to antibiotics in Klebsiella pneumoniae strains isolated from patients with hospital- and community-acquired infections in a Mexican medical center. Bautista-Cerón A, Monroy-Pérez E, García-Cortés LR, Rojas-Jiménez EA, Vaca-Paniagua F, Paniagua-Contreras GL. Microorganisms. 2022; 10:2043.
Carbapenem-resistant Klebsiella pneumoniae: the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge. Di Pilato V, Pollini S, Miriagou V, Rossolini GM, D'Andrea MM. Expert Rev Anti Infect Ther. 2024; 22:25–43.
P Dai, D. Hu.The making of hypervirulent Klebsiella pneumonia.J Clin Lab Anal. 2022; 36: p. e24743.
Early detection of OXA-232-producing Klebsiella pneumoniae in China predating its global emergence. Heng H, Yang X, Zhang H, et al. Microbiol Res. 2024; 282:127672.
Characteristics of non-carbapenemase producing carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China. Ruan Y, Li M, Wang D, Duan J, Zhang H, Zhou Y. J Infect Dev Ctries. 2024; 18:106–115.
Bacteriological characteristics of hypervirulent Klebsiella pneumoniae rmpA gene (hvKp-rmpA)-harboring strains in the south of Iran. Shoja S, Ansari M, Bengar S, Rafiei A, Shamseddin J, Alizade H. Iran J Microbiol. 2022; 14:475–483.
Yürek M, Cevahir N. Mikrobiyol. Investigation of virulence genes and carbapenem resistance genes in hypervirulent and classical isolates of Klebsiella pneumoniae isolated from various clinical specimens. Bul. 2023; 57:188–206.
Hypervirulent Klebsiella pneumoniae. Russo TA, Marr CM. Clin Microbiol Rev. 2019; 32:1–19.
Molecular characterization of Escherichia coli causing urinary tract infections through next-generation sequencing: a comprehensive analysis of serotypes, sequence types, and antimicrobial and virulence genes. Kandi V, Shahapur PR, Suvvari TK, et al. Cureus. 2024; 16:0
Marshall CR, Chowdhury S, Taft RJ, et al. Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease. NPJ Genom Med. 2020; 5:47
Chen Y, Huang J, Dong L, Xu B, Li L, Zhao Z, Li B. Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies. Front Cell Infect Microbiol. 2024; 14:1471477.
Yang J, Zhang K, Ding C, Wang S, Wu W, Liu X. BMC Microbiol. Exploring multidrug-resistant Klebsiella pneumoniae antimicrobial resistance mechanisms through whole genome sequencing analysis. 2023; 23:245.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute;
Zahra Hosseinzadeh et al. Emerge of bla NDM-1 and bla OXA-48-like harboring carbapenem-resistant Klebsiella pneumoniae isolates from hospitalized patients in southwestern Iran. Journal of the Chinese Medical Association. 2018; 81( 6): 536-540.
Jennifer H Han et al. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals. Clin Infect Di. 2016 ; 64(7):839–844.
Kaur Gill M. et al. Antibiogram of Klebsiella pneumoniae isolated from various clinical samples of hospitalized patients in a tertiary care hospital of North India. Tropical Journal of Pathology and Microbiology 2019; 5(8).
Biradar S, Roopa C. Isolation and Antibiogram of Klebsiella species from various clinical specimens. Int J Curr Microbiol App Sci. 2015; 4(9)991-5.
Da SilvaSF, ReiI, MonteiroM, et al. Influence of human eating habits on antimicrobial resistance phenomenon: aspects of clinical resistome of gut microbiota in omnivores, ovolactovegetarians, and strict vegetarians. Antibiotics. 2023; 10276.
Sarva Kamalakar et al. Molecular detection of blaNDM and blaOXA-48 genes in Carbapenem-Resistant Klebsiella pneumoniae isolates from a tertiary care hospital. Journal of King Saud University - Science. 2024; 36, Issue 7, 103233.
S.Mohanty, G. Mittal, R. Gaind. Identification of carbapenemase-mediated resistance among Enterobacteriaceae bloodstream isolates: a molecular study from India. Indian J. Med. Microbiol. 2017; 35 : pp. 421-425, 10.4103/ijmm.IJMM_16_386.
B. Veeraraghavan, C. Shankar, S. Karunasree, S. Kumari, R. Ravi, R. Ralph. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience. Pathog. Glob. Health., 2017; 111: pp. 240-246, 10.1080/20477724.2017.1340128
S.K. Pawar, S.T. Mohite, K.D. Datkhile, M.N. Patil, S.V. Kakade. Rising threat of OXA-48 and other carbapenemase encoding genes among carbapenem resistant Enterobacteriaceae in India. J. Pure Appl. Microbiol. 2020; 14: pp. 1917-1925, 10.22207/JPAM.14.3.30
Šuto S, Bedenic B, Likic S. Diffusion of OXA-48 carbapenemase among urinary isolates of Klebsiella
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
